Italy 3D Imaging Market Analysis

Italy 3D Imaging Market Analysis


$ 3999

Italy's 3D imaging market is projected to grow from $0.73 Bn in 2022 to $2.39 Bn by 2030, registering a CAGR of 16% during the forecast period of 2022-30. The market will be driven by accessibility to 3D imaging solutions and government-established programs to assist the development and use of 3D technology applications. The market is segmented by product, application, end-user & by portability. Some of the major players include Philips Healthcare, Siemens Healthineers & GE Healthcare

ID: IN10ITDH001 CATEGORY: Digital Health GEOGRAPHY: Italy AUTHOR: Vidhi Upadhyay

Buy Now

Italy 3D Imaging Market Executive Summary

Italy's 3D imaging market is projected to grow from $0.73 Bn in 2022 to $2.39 Bn by 2030, registering a CAGR of 16% during the forecast period of 2022-30. Italy's healthcare system is frequently ranked among the finest in the world. According to the World Health Organization (WHO) Global Health Expenditure database, healthcare spending in Italy in 2019 was $2,906, a 3.17% decrease from $3,001 in 2018 which was a 6.8% increase over 2017. The decline is expected to recover by 2024. According to Globocan 2020, the total incidence of all cancer was found to be 415 269. Out of which 13.3% were breast cancer cases, 11.7% were colorectum cases & 10.1% were lung cancer cases.

3D healthcare imaging is widely employed in Italy for a variety of medical purposes such as diagnosis, therapy planning, and surgical guiding. The use of 3D imaging in healthcare is projected to grow in the future years since it offers more precision and clarity than traditional 2D imaging methods.

In October 2022, The European Institute of Oncology in Milan, Italy, began providing AI-powered intraoperative 3D imaging to lung patients. Body Vision Medical, the global leader in AI-powered intraoperative imaging, revealed the installation of its first system in Europe at the IEO (European Institute of Oncology) in Milan, Italy. The imaging system uses AI to transform the X-ray images from any conventional C-arm into real-time, intraoperative 3D images.

Italy 3D imaging market analysis

Market Dynamics

Market Growth Drivers

The need for medical imaging treatments, particularly 3D imaging, is predicted to rise as individuals age and the frequency of chronic diseases such as cardiovascular disease and cancer rises. In recent years, technology has evolved tremendously, making 3D imaging more accessible and inexpensive. The Italian government has established programs to assist the development and use of healthcare technology, such as financing for research and development, tax deductions for healthcare enterprises, and medical device subsidies. Additionally, rising awareness among healthcare professionals and patients about the benefits of 3D imaging for medical applications is boosting demand for 3D imaging technology and adding to market development.

Market Restraints

The sector has significant problems because of the high cost of equipment and accompanying services. Because the funding for 3D imaging is restricted, patients who cannot pay the expense have limited access to the technology. Furthermore, traditional 2D imaging technologies compete with 3D imaging in Italy, and privacy concerns concerning the storage and transfer of sensitive patient data constitute a barrier to industry expansion. Unless adequately addressed, these challenges are projected to continue to impede the growth of the 3D imaging market in Italy. procedures and contributing to market growth.

Competitive Landscape

Key Players

  • Philips Healthcare
  • Siemens Healthineers
  • GE Healthcare
  • Toshiba Medical Systems
  • Hitachi Medical Systems
  • Dedalus (ITA)
  • I-MED Radiology Network (ITA)

Notable Deals

  1. November 2022, Philips enhanced AI-powered diagnostic technologies and transformational workflow solutions at RSNA 2022
  2. In October 2022, Philips revealed two significant advancements in MR-only procedures for head and neck cancer radiation imaging and simulation
  3. In September 2022, GE Healthcare’s deep-learning 3D imaging system received FDA-expanded approval. Also, it’s “AIR Recon DL” Received FDA Approval for 3D and Motion-Insensitive Imaging Applications for Superior Image Quality and Patient Experience in MRI

Healthcare Policies and Regulatory Landscape

The Ministry of Health and the Italian Medicines Agency (AIFA) controls the Italian healthcare sector. These organizations are in charge of developing medical device laws and regulations, including 3D imaging systems. Medical devices, especially 3D imaging systems, must conform with European Union (EU) standards as well as national requirements established by the Ministry of Health and the AIFA in Italy.

Reimbursement Scenario

In Italy, reimbursement for 3D imaging is provided solely by the National Health Service (Servizio Sanitario Nazionale), which covers the vast majority of the population. The National Health Service determines reimbursement for medical procedures, including 3D imaging, based on factors such as medical necessity and the availability of alternative therapies.

1. Executive Summary
1.1 Digital Health Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Digital Health Policy in Country
1.6 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Market Size (With Excel and Methodology)
2.2 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Italy 3D Imaging Market Segmentation

By Product (Revenue, USD Billion):

The 3D Imaging Market is divided majorly into X-ray Imaging Systems, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound & Nuclear Imaging Systems. X-ray Imaging systems have the highest market share in the 3D Imaging market. 3D X- rays are mostly utilized for dental and orthopedic applications. 3D Ultrasound is majorly helpful in tracking the dynamic motion of arteries, and veins and also has applications for various fetal, cardiac, obstetric, and rectal examinations, and many more. The ultrasound segment is predicted to develop substantially over the forecast period, primarily to the advancements in technology in the healthcare industry and the several advantages given by 3D ultrasound imaging over standard ultrasound imaging.

  • X-ray Imaging Systems
  • Computed Tomography (CT)
  • Magnetic Resonance Imaging (MRI)
  • Ultrasound
  • Nuclear Imaging systems

By Application (Revenue, USD Billion):

The market for 3D Imaging has applications covering Cardiology, Neurology, Orthopaedics, Gynaecology, Oncology, and other areas of diagnostics as well. Cardiovascular diseases are the leading cause of death globally. The second biggest cause is cancers because of which Oncology holds the highest market share in the 3D Imaging market followed by cardiology as 3D imaging is highly utilized in these two segments for diagnostics and treatments of the same. Neurosurgeons desire three-dimensional (3D) imagery of intracranial tumors, neural structures, skulls, and veins to establish a clear visual image of the surgical field's anatomical orientation prior to surgical intervention aiding better surgical outcomes for patients. Obstetricians employ 3D ultrasound scans to see the gestational sac, pinpoint the location of an ectopic pregnancy, and evaluate for fetal deformities of the face, spine, limbs, and heart. 3D Imaging applications for gynecology are yet in evolving stage and have a great scope for expansion allowing feasible and quick patient care.

  • Cardiology
  • Neurology
  • Orthopedics
  • Gynecology
  • Oncology
  • Others (Urology, etc.)

By End User (Revenue, USD Billion):

Hospitals, Diagnostic Imaging Centers, and other end-user such as private clinics make up the segments of the 3D Imaging Market. The hospitals among these hold the biggest market share due to the increased uptake of cutting-edge medical technology, the expansion of existing 3D Imaging facilities, the rising affordability of 3D Imaging services, the rising prevalence of chronic conditions such as cardiovascular diseases, cancers, respiratory diseases which lead to rising in demand for precise and quick diagnostic and treatment options. Diagnostic Imaging Centers have also been deploying 3D Imaging equipment to improve their standard of care.

  • Hospitals
  • Diagnostic Imaging Centers
  • Other End Users

By Portability (Revenue, USD Billion):

The 3D Imaging market is divided into two segments Stationary & Mobile, considering the portability of the device. Stationary 3D imaging involves equipment that is installed at a particular location and is operated from the same location of installment whereas mobile ones can be relatively smaller in size and hence moved to the patients who are unable to locate the Imaging room. Mobile MRI, Ultrasound, X–ray & CT allow cutting-edge healthcare to be delivered to nearly any location and are yet in the developing stages of expansion.

  • Stationary
  • Mobile

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 10 May 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up